Emtricitabine Structure (Emtricitabine Structure)
Emtricitabine And Tenofovir Disoproxil Fumarate
Product Images NDC 67296-1895
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 67296-1895). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (Container Label (30's count))
Each film-coated tablet contains 200 mg of emtricitabine and 300 mg of tenofovir disoproxil fumarate. The dosage and administration information can be found in the package insert. The tablets should be stored at a temperature ranging from 20° to 25°C (68° to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F). The container should be kept tightly closed, and the medication should only be dispensed in its original container. The product is manufactured for Laurus Generics Inc. and the manufacturing facility is located in Visekhiapatnam, India. The product is intended for prescription use only.*
Tenofovir Disoproxil Fumarate Structure (Tenofovir Df Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
